Previous Article | Next Article 
Molecular and Cellular Biology, January 2002, p. 669-679, Vol. 22, No. 2
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.22.2.669-679.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Brca2 (XRCC11) Deficiency Results in Radioresistant DNA Synthesis and a Higher Frequency of Spontaneous Deletions
Maria Kraakman-van der Zwet,1,2 Wilhelmina J. I. Overkamp,1,
Rebecca E. E. van Lange,1 Jeroen Essers,3 Annemarie van Duijn-Goedhart,1,2 Ingrid Wiggers,1 Srividya Swaminathan,4 Paul P. W. van Buul,1,2 Abdellatif Errami,1,2 Raoul T. L. Tan,3 Nicolaas G. J. Jaspers,3 Shyam K. Sharan,4 Roland Kanaar,3,5 and Ma
gorzata Z. Zdzienicka1,2*
Department of Radiation Genetics and Chemical Mutagenesis-MGC, Leiden University Medical Center,1
J. A. Cohen Institute, Interuniversity Research Institute for Radiopathology and Radiation Protection, Leiden,2
Department of Cell Biology and Genetics-MGC, Erasmus University,3
Mouse Cancer Genetics Program, National Cancer Institute-FCRDC, Frederick, Maryland,4
Department of Radiation Oncology, University Hospital Rotterdam/Daniel, Rotterdam, The Netherlands5
Received 11 June 2001/
Returned for modification 21 July 2001/
Accepted 8 October 2001
We show here that the radiosensitive Chinese hamster cell mutant (V-C8) of group XRCC11 is defective in the breast cancer susceptibility gene Brca2. The very complex phenotype of V-C8 cells is complemented by a single human chromosome 13 providing the BRCA2 gene, as well as by the murine Brca2 gene. The Brca2 deficiency in V-C8 cells causes hypersensitivity to various DNA-damaging agents with an extreme sensitivity toward interstrand DNA cross-linking agents. Furthermore, V-C8 cells show radioresistant DNA synthesis after ionizing radiation, suggesting that Brca2 deficiency affects cell cycle checkpoint regulation. In addition, V-C8 cells display tremendous chromosomal instability and a high frequency of abnormal centrosomes. The mutation spectrum at the hprt locus showed that the majority of spontaneous mutations in V-C8 cells are deletions, in contrast to wild-type V79 cells. A mechanistic explanation for the genome instability phenotype of Brca2-deficient cells is provided by the observation that the nuclear localization of the central DNA repair protein in homologous recombination, Rad51, is reduced in V-C8 cells.
* Corresponding author. Mailing address: Department of Radiation Genetics and Chemical Mutagenesis-MGC, Leiden University Medical Center, Wassenaarseweg 72, 2333 AL Leiden, The Netherlands. Phone: 31-71-527-6175. Fax: 31-71-527-6173. E-mail:
m.z.zdzienicka{at}lumc.nl.
Deceased.
Molecular and Cellular Biology, January 2002, p. 669-679, Vol. 22, No. 2
0022-538X/01/$04.00+0 DOI: 10.1128/MCB.22.2.669-679.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Ying, S., Myers, K., Bottomley, S., Helleday, T., Bryant, H. E.
(2009). BRCA2-dependent homologous recombination is required for repair of Arsenite-induced replication lesions in mammalian cells. Nucleic Acids Res
0: gkp538v1-gkp538
[Abstract]
[Full Text]
-
Gottipati, P., Helleday, T.
(2009). Transcription-associated recombination in eukaryotes: link between transcription, replication and recombination. Mutagenesis
24: 203-210
[Abstract]
[Full Text]
-
Savolainen, L., Helleday, T.
(2009). Transcription-associated recombination is independent of XRCC2 and mechanistically separate from homology-directed DNA double-strand break repair. Nucleic Acids Res
37: 405-412
[Abstract]
[Full Text]
-
Kyle, S, Thomas, H D, Mitchell, J, Curtin, N J
(2008). Exploiting the Achilles heel of cancer: the therapeutic potential of poly(ADP-ribose) polymerase inhibitors in BRCA2-defective cancer. Br. J. Radiol.
81: S6-S11
[Abstract]
[Full Text]
-
Valli, C., Paroni, G., Di Francesco, A. M., Riccardi, R., Tavecchio, M., Erba, E., Boldetti, A., Gianni', M., Fratelli, M., Pisano, C., Merlini, L., Antoccia, A., Cenciarelli, C., Terao, M., Garattini, E.
(2008). Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity. Molecular Cancer Therapeutics
7: 2941-2954
[Abstract]
[Full Text]
-
Ashworth, A.
(2008). A Synthetic Lethal Therapeutic Approach: Poly(ADP) Ribose Polymerase Inhibitors for the Treatment of Cancers Deficient in DNA Double-Strand Break Repair. JCO
26: 3785-3790
[Abstract]
[Full Text]
-
Hucl, T., Rago, C., Gallmeier, E., Brody, J. R., Gorospe, M., Kern, S. E.
(2008). A Syngeneic Variance Library for Functional Annotation of Human Variation: Application to BRCA2. Cancer Res.
68: 5023-5030
[Abstract]
[Full Text]
-
Li, P. C.H., Lam, E., Roos, W. P., Zdzienicka, M. Z., Kaina, B., Efferth, T.
(2008). Artesunate Derived from Traditional Chinese Medicine Induces DNA Damage and Repair. Cancer Res.
68: 4347-4351
[Abstract]
[Full Text]
-
Farrugia, D. J., Agarwal, M. K., Pankratz, V. S., Deffenbaugh, A. M., Pruss, D., Frye, C., Wadum, L., Johnson, K., Mentlick, J., Tavtigian, S. V., Goldgar, D. E., Couch, F. J.
(2008). Functional Assays for Classification of BRCA2 Variants of Uncertain Significance. Cancer Res.
68: 3523-3531
[Abstract]
[Full Text]
-
Daboussi, F., Courbet, S., Benhamou, S., Kannouche, P., Zdzienicka, M. Z., Debatisse, M., Lopez, B. S.
(2008). A homologous recombination defect affects replication-fork progression in mammalian cells. J. Cell Sci.
121: 162-166
[Abstract]
[Full Text]
-
Soares, D. G., Escargueil, A. E., Poindessous, V., Sarasin, A., de Gramont, A., Bonatto, D., Henriques, J. A. P., Larsen, A. K.
(2007). From the Cover: Replication and homologous recombination repair regulate DNA double-strand break formation by the antitumor alkylator ecteinascidin 743. Proc. Natl. Acad. Sci. USA
104: 13062-13067
[Abstract]
[Full Text]
-
Hinz, J. M., Nham, P. B., Urbin, S. S., Jones, I. M., Thompson, L. H.
(2007). Disparate contributions of the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis. Nucleic Acids Res
35: 3733-3740
[Abstract]
[Full Text]
-
Gallmeier, E., Kern, S. E.
(2007). Targeting Fanconi Anemia/BRCA2 Pathway Defects in Cancer: The Significance of Preclinical Pharmacogenomic Models. Clin. Cancer Res.
13: 4-10
[Abstract]
[Full Text]
-
Harris, J., Lowden, M., Clejan, I., Tzoneva, M., Thomas, J. H., Hodgkin, J., Ahmed, S.
(2006). Mutator Phenotype of Caenorhabditis elegans DNA Damage Checkpoint Mutants. Genetics
174: 601-616
[Abstract]
[Full Text]
-
McCabe, N., Turner, N. C., Lord, C. J., Kluzek, K., Bialkowska, A., Swift, S., Giavara, S., O'Connor, M. J., Tutt, A. N., Zdzienicka, M. Z., Smith, G. C.M., Ashworth, A.
(2006). Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition. Cancer Res.
66: 8109-8115
[Abstract]
[Full Text]
-
Saeki, H., Siaud, N., Christ, N., Wiegant, W. W., van Buul, P. P. W., Han, M., Zdzienicka, M. Z., Stark, J. M., Jasin, M.
(2006). Suppression of the DNA repair defects of BRCA2-deficient cells with heterologous protein fusions. Proc. Natl. Acad. Sci. USA
103: 8768-8773
[Abstract]
[Full Text]
-
Pscherer, A., Schliwka, J., Wildenberger, K., Mincheva, A., Schwaenen, C., Dohner, H., Stilgenbauer, S., Lichter, P.
(2006). Antagonizing inactivated tumor suppressor genes and activated oncogenes by a versatile transgenesis system: application in mantle cell lymphoma. FASEB J.
20: 1188-1190
[Abstract]
[Full Text]
-
Filippo, J. S., Chi, P., Sehorn, M. G., Etchin, J., Krejci, L., Sung, P.
(2006). Recombination Mediator and Rad51 Targeting Activities of a Human BRCA2 Polypeptide. J. Biol. Chem.
281: 11649-11657
[Abstract]
[Full Text]
-
McAllister, K. A., Houle, C. D., Malphurs, J., Ward, T., Collins, N. K., Gersch, W., Wharey, L., Seely, J. C., Betz, L., Bennett, L. M., Wiseman, R. W., Davis, B. J.
(2006). Spontaneous and Irradiation-Induced Tumor Susceptibility in Brca2 Germline Mutant Mice and Cooperative Effects with a p53 Germline Mutation. Toxicol Pathol
34: 187-198
[Abstract]
[Full Text]
-
Hay, T., Jenkins, H., Sansom, O. J., Martin, N. M.B., Smith, G. C.M., Clarke, A. R.
(2005). Efficient Deletion of Normal Brca2-Deficient Intestinal Epithelium by Poly(ADP-Ribose) Polymerase Inhibition Models Potential Prophylactic Therapy. Cancer Res.
65: 10145-10148
[Abstract]
[Full Text]
-
Ohashi, A., Zdzienicka, M. Z., Chen, J., Couch, F. J.
(2005). Fanconi Anemia Complementation Group D2 (FANCD2) Functions Independently of BRCA2- and RAD51-associated Homologous Recombination in Response to DNA Damage. J. Biol. Chem.
280: 14877-14883
[Abstract]
[Full Text]
-
Kojic, M., Zhou, Q., Lisby, M., Holloman, W. K.
(2005). Brh2-Dss1 Interplay Enables Properly Controlled Recombination in Ustilago maydis. Mol. Cell. Biol.
25: 2547-2557
[Abstract]
[Full Text]
-
Hatanaka, A., Yamazoe, M., Sale, J. E., Takata, M., Yamamoto, K., Kitao, H., Sonoda, E., Kikuchi, K., Yonetani, Y., Takeda, S.
(2005). Similar Effects of Brca2 Truncation and Rad51 Paralog Deficiency on Immunoglobulin V Gene Diversification in DT40 Cells Support an Early Role for Rad51 Paralogs in Homologous Recombination. Mol. Cell. Biol.
25: 1124-1134
[Abstract]
[Full Text]
-
Wu, K., Hinson, S. R., Ohashi, A., Farrugia, D., Wendt, P., Tavtigian, S. V., Deffenbaugh, A., Goldgar, D., Couch, F. J.
(2005). Functional Evaluation and Cancer Risk Assessment of BRCA2 Unclassified Variants. Cancer Res.
65: 417-426
[Abstract]
[Full Text]
-
TUTT, A.N.J., LORD, C.J., MCCABE, N., FARMER, H., TURNER, N., MARTIN, N.M., JACKSON, S.P., SMITH, G.C.M., ASHWORTH, A.
(2005). Exploiting the DNA Repair Defect in BRCA Mutant Cells in the Design of New Therapeutic Strategies for Cancer. Cold Spring Harb Symp Quant Biol
70: 139-148
[Abstract]
-
Surralles, J., Jackson, S. P., Jasin, M., Kastan, M. B., West, S. C., Joenje, H.
(2004). Molecular cross-talk among chromosome fragility syndromes. Genes Dev.
18: 1359-1370
[Full Text]
-
Kraakman-van der Zwet, M., Wiegant, W. W., Zdzienicka, M. Z.
(2003). Brca2 (XRCC11) deficiency results in enhanced mutagenesis. Mutagenesis
18: 521-525
[Abstract]
[Full Text]
-
Schultz, N., Lopez, E., Saleh-Gohari, N., Helleday, T.
(2003). Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination. Nucleic Acids Res
31: 4959-4964
[Abstract]
[Full Text]
-
D'Andrea, A. D.
(2003). The Fanconi road to cancer. Genes Dev.
17: 1933-1936
[Full Text]
-
Pihan, G. A., Wallace, J., Zhou, Y., Doxsey, S. J.
(2003). Centrosome Abnormalities and Chromosome Instability Occur Together in Pre-invasive Carcinomas. Cancer Res.
63: 1398-1404
[Abstract]
[Full Text]
-
Shima, N., Hartford, S. A., Duffy, T., Wilson, L. A., Schimenti, K. J., Schimenti, J. C.
(2003). Phenotype-Based Identification of Mouse Chromosome Instability Mutants. Genetics
163: 1031-1040
[Abstract]
[Full Text]
-
Bessho, T.
(2003). Induction of DNA Replication-mediated Double Strand Breaks by Psoralen DNA Interstrand Cross-links. J. Biol. Chem.
278: 5250-5254
[Abstract]
[Full Text]
-
Donahue, S. L., Campbell, C.
(2002). A DNA Double Strand Break Repair Defect in Fanconi Anemia Fibroblasts. J. Biol. Chem.
277: 46243-46247
[Abstract]
[Full Text]
-
Godthelp, B. C., Wiegant, W. W., van Duijn-Goedhart, A., Scharer, O. D., van Buul, P. P. W., Kanaar, R., Zdzienicka, M. Z.
(2002). Mammalian Rad51C contributes to DNA cross-link resistance, sister chromatid cohesion and genomic stability. Nucleic Acids Res
30: 2172-2182
[Abstract]
[Full Text]
-
D'Andrea, A. D., Dahl, N., Guinan, E. C., Shimamura, A.
(2002). Marrow Failure. ASH Education Book
2002: 58-72
[Abstract]
[Full Text]